Institutional Ownership Cogent Biosciences, Inc. (COGT)
This table provides information about the institutional ownership of Cogent Biosciences, Inc. (COGT). We have compiled data on the 203 institutions that hold shares in the stock, with a total of 117 Million shares, which have been reported (via 13F filing form) to have a value of $1.35 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Paradigm Biocapital Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
10,352,449
shares
|
$120 Million
3.47% of portfolio
|
Q2 2025
Added 15.49%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Aug 14, 2025 Q2 2025 |
8,492,557
shares
|
$98.1 Million
7.28% of portfolio
|
Q2 2025
Reduced 6.73%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,288,378
shares
|
$84.2 Million
0.0% of portfolio
|
Q2 2024
Added 8.95%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Aug 14, 2025 Q2 2025 |
6,964,375
shares
|
$80.4 Million
10.2% of portfolio
|
Q2 2024
Added 12.07%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
6,522,951
shares
|
$75.3 Million
0.0% of portfolio
|
Q2 2025
Added 7.67%
|
|
|
Fairmount Funds Management LLC
Philadelphia, PA |
Aug 14, 2025 Q2 2025 |
6,225,641
shares
|
$71.9 Million
13.7% of portfolio
|
Q2 2024
Added 31.74%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Aug 14, 2025 Q2 2025 |
4,911,924
shares
|
$56.7 Million
0.08% of portfolio
|
Q2 2025
Reduced 7.24%
|
|
|
Vr Adviser, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
4,755,411
shares
|
$54.9 Million
6.76% of portfolio
|
Q2 2025
Reduced 16.34%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
3,518,671
shares
|
$40.6 Million
0.0% of portfolio
|
Q2 2025
Added 13.35%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
3,371,912
shares
|
$38.9 Million
0.0% of portfolio
|
Q2 2025
Reduced 18.09%
|
|
|
Vestal Point Capital, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
3,080,000
shares
|
$35.6 Million
1.16% of portfolio
|
Q2 2025
Added 2.67%
|
|
|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
2,873,053
shares
|
$33.2 Million
0.01% of portfolio
|
Q2 2025
Added 9782.2%
|
|
|
Octagon Capital Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
2,763,000
shares
|
$31.9 Million
7.53% of portfolio
|
Q1 2025
Added 31.95%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,672,113
shares
|
$30.9 Million
0.0% of portfolio
|
Q2 2025
Added 10.61%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Aug 14, 2025 Q2 2025 |
2,640,215
shares
|
$30.5 Million
0.44% of portfolio
|
Q2 2025
Added 0.24%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
2,355,505
shares
|
$27.2 Million
1.15% of portfolio
|
Q2 2025
Added 7.95%
|
|
|
Commodore Capital LP
New York, NY |
Aug 14, 2025 Q2 2025 |
2,311,164
shares
|
$26.7 Million
1.55% of portfolio
|
Q2 2025
Reduced 74.01%
|
|
|
Saturn V Capital Management LLC
Austin, TX |
Aug 13, 2025 Q2 2025 |
2,297,524
shares
|
$26.5 Million
6.69% of portfolio
|
Q2 2025
Added 55.24%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
1,734,601
shares
|
$20 Million
0.66% of portfolio
|
Q2 2025
Added 85.21%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Aug 14, 2025 Q2 2025 |
1,655,689
shares
|
$19.1 Million
0.52% of portfolio
|
Q2 2025
Added 96.29%
|
|
|
Redmile Group, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
1,448,040
shares
|
$16.7 Million
1.27% of portfolio
|
Q2 2025
Reduced 54.97%
|
|
|
Emerald Advisers, LLC
|
Aug 04, 2025 Q2 2025 |
1,445,774
shares
|
$16.7 Million
0.41% of portfolio
|
Q2 2025
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
1,400,965
shares
|
$16.2 Million
0.0% of portfolio
|
Q2 2025
Added 30.78%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,229,121
shares
|
$14.2 Million
0.0% of portfolio
|
Q2 2025
Reduced 3.65%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,200,437
shares
|
$13.9 Million
0.0% of portfolio
|
Q2 2025
Added 21.38%
|